Header cover image

German Pharmaceuticals & Biotech Established, Profitable and Undervalued

UPDATED May 18, 2022

Over $1bn in market cap, profitable and undervalued based on cash flows.

2 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
MRKMERCK Kommanditgesellschaft auf Aktien€163.95-3.3%14.8%€71.3b€214.16PS22.4xE6.2%1.1%
BAYNBayer€63.809.9%14.6%€62.7b€77.40PS28.5xE8.2%3.1%
Page 1 of 1